ARIN ABRAMIAN: Open Payments
NPI 1487033213 · SIMI VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 12 payments from 6 companies in 2025. Trend: 2023 $663 · 2024 $1,289 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $138 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| Collegium Pharmaceutical, Inc. | 6 | $112 |
| Virtus Pharmaceuticals LLC | 2 | $45 |
| IBSA Pharma Inc. | 1 | $14 |
Products named: Korlym, NEFFY, MOUNJARO, Belbuca, LEVORPHANOL TARTRATE, XTAMPZA, Tirosint.
Industry payments across CA — which companies pay providers there.
